SCHEMBL4672830

SCHEMBL4672830

O=C(c1ccc(F)cc1F)C1CCNCC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.52
CES1 P23141 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.51
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 2/20 0.47
MAPT P10636 1/20 0.47
NPY2R P49146 1/20 0.47
HTR3E A5X5Y0 1/20 0.47
HTR3B O95264 1/20 0.47
HTR3A P46098 1/20 0.47
HTR3D Q70Z44 1/20 0.47
HTR3C Q8WXA8 1/20 0.47
CYP2D6 P10635 1/20 0.45
CPS1 P31327 1/20 0.44
ACKR3 P25106 1/20 0.42
HSD11B1 P28845 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1836446 0.98 CES2 (0.50) CES2CES1L3MBTL1MEN1KMT2A
Fumaric Acid SCHEMBL10637939 0.91 SLC6A2 (0.50) CES2CES1L3MBTL1MEN1KMT2A
Fumaric Acid SCHEMBL10637950 0.91 SLC6A2 (0.50) CES2CES1L3MBTL1MEN1KMT2A
SCHEMBL6141006 0.90 L3MBTL1 (0.61) CES2CES1L3MBTL1MEN1KMT2A
SCHEMBL20524724 0.87 CES2 (0.52) CES2CES1L3MBTL1MEN1KMT2A
SCHEMBL30323082 0.87 CES2 (0.52) CES2CES1L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL15567881 0.85 CES2 (0.50) CES2CES1L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL31196625 0.85 CES2 (0.50) CES2CES1L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL10964891 0.84 MEN1 (0.46) CES2CES1L3MBTL1MEN1KMT2A
SCHEMBL226059 0.84 HSD11B1 (0.54) MEN1KMT2AALDH1A1HTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118641654-B Method for detecting related substances of 4- (2, 4-difluorobenzoyl) -piperidine hydrochloride serving as initial raw material of paliperidone 山东泰合医药科技有限公司 2024-12-17 CN claimed
CN-118641654-A Method for detecting related substances of 4- (2, 4-difluorobenzoyl) -piperidine hydrochloride serving as initial raw material of paliperidone 山东泰合医药科技有限公司 2024-09-13 CN claimed
CN-118561742-A Rupestonic acid amide derivative containing nitrogen heterocycle, and preparation method and application thereof 中国科学院新疆理化技术研究所 2024-08-30 CN claimed
CN-115057809-B Preparation method of 4- (2, 4-difluorobenzoyl) -piperidine 扬州市普林斯医药科技有限公司 2024-02-13 CN claimed
CN-115057809-A Preparation method of 4- (2, 4-difluorobenzoyl) -piperidine 扬州市普林斯医药科技有限公司 2022-09-16 CN claimed
CN-106831742-B A kind of preparation method of Iloperidone intermediate 北京医药集团有限责任公司 2019-08-23 CN claimed
CN-106831742-A A kind of preparation method of Iloperidone intermediate 北京医药集团有限责任公司 2017-06-13 CN claimed
CN-102796090-B Method for preparing iloperidone TIANJIN HUAJIN PHARMACEUTICAL CO LTD 2015-03-25 CN claimed
US-4408053-A ANALGESICS HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1983-10-04 US claimed
CN-118641654-B Method for detecting related substances of 4- (2, 4-difluorobenzoyl) -piperidine hydrochloride serving as initial raw material of paliperidone 山东泰合医药科技有限公司 2024-12-17 CN disclosed
CN-118641654-A Method for detecting related substances of 4- (2, 4-difluorobenzoyl) -piperidine hydrochloride serving as initial raw material of paliperidone 山东泰合医药科技有限公司 2024-09-13 CN disclosed
CN-118561742-A Rupestonic acid amide derivative containing nitrogen heterocycle, and preparation method and application thereof 中国科学院新疆理化技术研究所 2024-08-30 CN disclosed
CN-115057809-B Preparation method of 4- (2, 4-difluorobenzoyl) -piperidine 扬州市普林斯医药科技有限公司 2024-02-13 CN disclosed
CN-115057809-B Preparation method of 4- (2, 4-difluorobenzoyl) -piperidine 扬州市普林斯医药科技有限公司 2024-02-13 CN disclosed
US-5100902-A Dopamine and Serotonin Antagonists, Antipsychotic Agents ADIR ET COMPAGNIE (FR) 1992-03-31 US disclosed
EP-0428437-A1 1,2-Benzisoxazole derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1991-05-22 EP disclosed
CN-1049161-A Heterogeneous ring compound with serotonine 2-receptor antagonistic activity DAIICHI SEIYAKU CO (JP) 1991-02-13 CN disclosed
EP-0401707-A1 Heterocyclic triazin or triazolo compounds having serotonin 2-receptor antagonistic activity DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1990-12-12 EP disclosed
US-4804663-A PSYCHOLOGICAL DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 1989-02-14 US disclosed
EP-0196132-A2 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1986-10-01 EP disclosed